Pharmaceuticals in the environment: An educational perspective

Environmental Science and Pollution Research

Volumn 18, Issue 9, 2011, Pages 1555-1566

  Eissen, Marco ^a   Backhaus, Donata ^a  

^a Gymnasium Ganderkesee ^*  (Germany)

Author keywords

Degradability; Educational material; Endocrine disruptors; Environmental risks; Green pharmacy; Mixtures; Risk mitigation; Water contamination

Indexed keywords

DRUG; ENDOCRINE DISRUPTOR;

BIOSOLID; CURRICULUM; DEGRADATION; DRUG; EDUCATIONAL DEVELOPMENT; ENDOCRINE DISRUPTOR; ENVIRONMENTAL EDUCATION; ENVIRONMENTAL EFFECT; ENVIRONMENTAL FATE; ENVIRONMENTAL RISK; INTERNET; LITERATURE REVIEW; RETENTION; RISK ASSESSMENT; WASTE TREATMENT; WASTEWATER; WATER POLLUTION;

ARTICLE; BIOREMEDIATION; EDUCATION; ENVIRONMENTAL MONITORING; HALF LIFE TIME; INDUSTRIAL WASTE; ISOLATION AND PURIFICATION; METHODOLOGY; POLLUTION; PRACTICE GUIDELINE; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; WATER POLLUTANT;

BIODEGRADATION, ENVIRONMENTAL; EDUCATION, PHARMACY; ENDOCRINE DISRUPTORS; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTION; GUIDELINES AS TOPIC; HALF-LIFE; INDUSTRIAL WASTE; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; WATER POLLUTANTS, CHEMICAL;

EID: 80053961820     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-011-0512-6     Document Type: Article

References (105)

1. Aitken RJ, Koopman P, Lewis SEM (2004) Seeds of concern. Nature 432: 48-52.
2. Alfonsi K, Colberg J, Dunn PJ, Fevig T, Jennings S, Johnson TA, Kleine HP, Knight C, Nagy MA, Perry DA, Stefaniak M (2008) Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation. Green Chem 10: 31-36.
3. Barrett JR (2009) The Yin and Yang of exposure: chemical combinations may explain feminization of wild fish. Environ Health Perspect 117: A210.
4. Bedner M, MacCrehan WA (2005) Transformation of acetaminophen by chlorination produces the toxicants 1, 4-benzoquinone and N-acetyl-p-benzoquinone imine. Environ Sci Technol 40: 516-522.
5. Boethling RS, Sommer E, DiFiore D (2007) Designing small molecules for biodegradability. Chem Rev 107: 2207-2227.
6. Bögershausen K, Parchmann I (1996) Denitrifikation von Trinkwasser Demonstration im Schulversuch. CHEMKON 3: 187-189.
7. Böschen S, Lenoir D, Scheringer M (2003) Sustainable chemistry: starting points and prospects. Naturwissenschaften 90: 93-102.
8. Caliman FA, Gavrilescu M (2009) Pharmaceuticals, personal care products and endocrine disrupting agents in the environment-a review. Clean-Soil Air Water 37: 277-303.
9. Carvalho I, Borges ADL, Bernardes LSC (2005) Medicinal chemistry and molecular modeling: an integration to teach drug structure-activity relationship and the molecular basis of drug action. J Chem Educ 82: 588-596.
10. Castensson S, Eriksson V, Lindborg K, Br W (2009) A method to include the environmental hazard in drug prescribing. Pharm World Sci 31: 24-31.
11. Chen XB, Halasz SM, Giles EC, Mankus JV, Johnson JC, Burda C (2006) A simple parallel photochemical reactor for photodecomposition studies. J Chem Educ 83: 265-267.
12. Christen V, Hickmann S, Rechenberg B, Fent K (2010) Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat Toxicol 96: 167-181.
13. Colucci MS, Topp E (2001) Persistence of estrogenic hormones in agricultural soils: II. 17 alpha-ethynylestradiol. J Environ Qual 30: 2077-2080.
14. Committee for Medicinal Products for Human Use (2006) Guideline on the environmental risk assessment of medicinal products for human use. Report no. EMEA/CHMP/SWP/4447/00. European Medicines Agency, London. http://www. ema. europa. eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003978. pdf. Accessed 7 Nov 2010.
15. Cooper ER, Siewicki TC, Phillips K (2008) Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Sci Total Environ 398: 26-33.
16. Crane M, Watts C, Boucard T (2006) Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Total Environ 367: 23-41.
17. Daughton CG (2003a) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ Health Perspect 111: 757-774.
18. Daughton CG (2003b) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ Health Perspect 111: 775-785.
19. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107: 907-938.
20. Deffner J, Götz K (2008) Handlungsoptionen für einen umweltfreundlicheren Umgang mit Arzneimitteln. Umweltwiss Schadst Forsch 20: 238-248.
21. Dhawale SW (1993) Introducing the treatment of waste and wastewater in the general chemistry course: applying physical and chemical principles to the problems of waste management. J Chem Educ 70: 395-397.
22. Dodd MC, Buffle M-O, von Gunten U (2006) Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ Sci Technol 40: 1969-1977.
23. Doerr-MacEwen NA, Haight ME (2006) Expert stakeholders' views on the management of human pharmaceuticals in the environment. Environ Manage 38: 853-866.
24. Dorne J, Ragas AMJ, Frampton GK, Spurgeon DS, Lewis DF (2007a) Trends in human risk assessment of pharmaceuticals. Anal Bioanal Chem 387: 1167-1172.
25. Dorne J, Skinner L, Frampton G, Spurgeon D, Ragas A (2007b) Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal Bioanal Chem 387: 1259-1268.
26. Eissen M, Metzger JO, Schmidt E, Schneidewind U (2002) 10 years after Rio-concepts on the contribution of chemistry to a sustainable development. Angew Chem Int Ed 41: 414-436.
27. Eissen M, Kaling S, Strudthoff M, Backhaus S, Eismann C, Oetken G, Lenoir D (2011) Oxidation numbers, oxidants, and redox reactions: variants of the electrophilic bromination of alkenes and variants of the application of oxone. J Chem Educ 88: 284-291.
28. European Parliament (2004) Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. European Parliament, Strasbourg. http://ec. europa. eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2004_27/dir_2004_27_en. pdf; in German: http://eur-lex. europa. eu/LexUriServ/LexUriServ. do?uri=OJ: L: 2004: 136: 0034: 0057: DE: PDF. Accessed 12 Mar 2009.
29. Evans AL, Messersmith RE, Green DB, Fritsch JM (2011) Degradation of environmental contaminants with water-soluble cobalt catalysts: an integrative inorganic chemistry investigation. J Chem Educ 88: 204-208.
30. Federsel HJ (2006) In search of sustainability: process R& D in light of current pharmaceutical industry challenges. Drug Discov Today 11: 966-974.
31. Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
32. Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenström J, Wallensten A, Olsen B (2007) Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2: 1-5.
33. Ginebreda A, Muñoz I, de Alda ML, Brix R, López-Doval J, Barceló D (2010) Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ Int 36: 153-162.
34. Grguric G (2002) Denitrification as a model chemical process. J Chem Educ 79: 179-182.
35. Gros M (2010, personal communication) Personal communication with Meritxell Gros allowed us to identify two errors in Table 3 of the reference [Gros M, Petrovic M, Barceló D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environ. Toxicol. Chem. 26: 1553-1562]. (1) Table 3, WWTP2: analgesics and anti-inflammatories in influent wastewaters were 0. 3 g/day/1000 inhabitants instead of 1. 60 g/day/1000 inhabitants. (2) Measuring results being noted below "WWTP3" have to change the place with those being noted below "WWTP2". A correct presentation of the total loads is illustrated with Figure 1 in reference [Petrovic M, de Alda MJL, Diaz-Cruz S, Postigo C, Radjenovic J, Gros M, Barcelo D (2009) Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos. Trans. R. Soc. London, Ser. A 367: 3979-4003].
36. Gros M, Petrovic M, Barceló D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environ Toxicol Chem 26: 1553-1562.
37. Gros M, Petrovic M, Ginebreda A, Barceló D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36: 15-26.
38. Gunnarsson B, Wennmalm Å (2006) Environmental risk assessment and environmental classification of drugs. In: Bengtsson B-E, Gunnarsson B, Wall T, Wennmalm Å (eds) Environment and pharmaceuticals. Apoteket AB (The National Corporation of Swedish Pharmacies), Stockholm County Council and Stockholm University, pp 117-125. http://www. janusinfo. se/Global/Miljo_och_lakemedel/lakemed_miljo_eng2007. pdf. Accessed 26 Mar 2011.
39. Hansmann R, Mieg HA, Frischknecht PM (2010) Qualifications for contributing to sustainable development. A survey of environmental sciences graduates. Gaia-Ecol Perspect Sci Soc 19: 278-286.
40. Harremoës P, Gee D, MacGarvin M, Stirling A, Keys J, Wynne B, Guedes Vaz S (2002) Late lessons from early warnings: the precautionary principle 1896-2000. OPOCE (Office for Official Publications of the European Communities), Copenhagen. http://www. eea. europa. eu/publications/environmental_issue_report_2001_22; in German: http://www. umweltdaten. de/publikationen/fpdf-l/2697. pdf. Accessed 2 May 2011.
41. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131: 5-17.
42. Hernandez MA, Czerwinska J (2008) A web-based interactive module to teach acid-base principles of drug action. J Chem Educ 85: 1704.
43. Hernando MD, Fernández-Alba AR, Tauler R, Barceló D (2005) Toxicity assays applied to wastewater treatment. Talanta 65: 358-366.
44. Hickman RJS, Neill J (1997) Influence of pH on drug absorption from the gastrointestinal tract-a simple chemical model. J Chem Educ 74: 855-856.
45. Huber MM, Göbel A, Joss A, Hermann N, Löffler D, McArdell CS, Ried A, Siegrist H, Ternes TA, von Gunten U (2005) Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ Sci Technol 39: 4290-4299.
46. Hutchinson TH, Beesley A, Frickers PE, Readman JW, Shaw JP, Straub JO (2009) Extending the environmental risk assessment for oseltamivir (Tamiflu (R)) under pandemic use conditions to the coastal marine compartment. Environ Int 35: 931-936.
47. Institute for Social-Ecological Research GmbH (2008) Start: management strategies for pharmaceutical residues in drinking water-pharmaceuticals for human use: options of action for reducing the contamination of water bodies-a practical guide. http://www. start-project. de/downloads/start_Practical_Guide. pdf (in German: http://www. start-project. de/downloads/start. pdf). Accessed 29 Jan 2010.
48. Jacobsen EK (2004) Water filtration. J Chem Educ 81: 224A.
49. Jones-Lepp TL, Stevens R (2007) Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation. Anal Bioanal Chem 387: 1173-1183.
50. Keil F, Bechmann G, Kümmerer K, Schramm E (2008) Systemic risk governance for pharmaceutical residues in drinking water. GAIA - Ecol Perspect Sci Soc 17: 355-361.
51. Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 107: 2319-2364.
52. Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW (2007) Collapse of a fish population after exposure to a synthetic estrogen. P Natl Acad Sci USA 104: 8897-8901.
53. Kümmerer K (2007) Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry. Green Chem 9: 899-907.
54. Kümmerer K (2009) The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges. J Environ Manage 90: 2354-2366.
55. Kümmerer K, Schramm E (2008) Arzneimittelentwicklung: Die Reduzierung von Umweltbelastungen durch gezieltes Moleküldesign. Umweltwiss Schadst Forsch 20: 249-263.
56. Längin A, Schuster A, Kümmerer K (2008) Chemicals in the environment-the need for a clear nomenclature: parent compounds, metabolites, transformation products and their elimination. CLEAN - Soil, Air, Water 36: 349-350.
57. Lubick N (2008) Opening the "green pharmacy". Environ Sci Technol 42: 8620-8621.
58. Luehrs DC, Roher AE (2007) Demonstration of the Fenton reaction. J Chem Educ 84: 1290-1291.
59. Lund T (1999-2004) Working Document 21. 06. 2000, Endocrine disrupting substances-background paper, European Parliament, Committee on the Environment, Public Health and Consumer Policy. http://www. europarl. europa. eu/meetdocs/committees/envi/20000710/413253_en. doc. Accessed 10 Jan 2010.
60. Lundgren A (2006) Assessment in the chemicals control of environmental hazards and risks. In: Bengtsson B-E, Gunnarsson B, Wall T, Wennmalm Å (eds) Environment and Pharmaceuticals. Apoteket AB (The National Corporation of Swedish Pharmacies), Stockholm County Council and Stockholm University, 105-115, pp 117-125. http://www. janusinfo. se/Global/Miljo_och_lakemedel/lakemed_miljo_eng2007. pdf. Accessed 26 Mar 2011.
61. Mailhot G, Sarakha M, Lavedrine B, Cáceres J, Malato S (2002) Fe(III)-solar light induced degradation of diethyl phthalate (DEP) in aqueous solutions. Chemosphere 49: 525-532.
62. Marks R, Eilks I (2010) Research-based development of a lesson plan on shower gels and musk fragrances following a socio-critical and problem-oriented approach to chemistry teaching. Chem Educ Res Pract 11: 129-141.
63. McDowell DC, Huber MM, Wagner M, von Gunten U, Ternes TA (2005) Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products. Environ Sci Technol 39: 8014-8022.
64. Miles WH, Smiley PM (2002) Modeling the drug discovery process: the isolation and biological testing of eugenol from clove oil. J Chem Educ 79: 90.
65. Monteiro SC, Boxall ABA (2010) Occurrence and fate of human pharmaceuticals in the environment. In: Whitacre DM (ed) Reviews of environmental contamination and toxicology, vol 202. Springer, New York, pp 53-154, < Go to ISI>://000272540400002.
66. Nash JJ, Meyer JAR, Nurrenbern SC (1996) Waste treatment in the undergraduate laboratory: let the students do it! J Chem Educ 73: 1183-1185.
67. Nikolaou A, Meric S, Fatta D (2007) Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 387: 1225-1234.
68. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Iqbal Chaudhry MJ, Arshad M, Mahmood S, Ali A, Ahmed Khan A (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427: 630-633.
69. Pain DJ, Bowden CGR, Cunningham AA, Cuthbert R, Das D, Gilbert M, Jakati RD, Jhala Y, Khan AA, Naidoo V, Oaks JL, Parry-Jones J, Prakash V, Rahman A, Ranade SP, Baral HS, Senacha KR, Saravanan S, Shah N, Swan G, Swarup D, Taggart MA, Watson RT, Virani MZ, Wolter K, Green RE (2008) The race to prevent the extinction of South Asian vultures. Bird Conserv Int 18: S30-S48.
70. Petrovic M, de Alda MJL, Diaz-Cruz S, Postigo C, Radjenovic J, Gros M, Barcelo D (2009) Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos Trans R Soc Lond A 367: 3979-4003.
71. Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E (2008) Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 102: 129-137.
72. Prasse C, Schlüsener MP, Schulz R, Ternes TA (2010) Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ Sci Technol 44: 1728-1735.
73. Price LB, Johnson E, Vailes R, Silbergeld E (2005) Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environ Health Perspect 113: 557-560.
74. Price LB, Lackey LG, Vailes R, Silbergeld E (2007) The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect 115: 1035-1039.
75. Prüße U, Vorlop K-D (1996) Entfernung von Nitrat aus Trinkwasser. CHEMKON 3: 62-67.
76. Radke M (2010) Personal communication: the data demonstrated in the worksheet table were provided by Michael Radke.
77. Radke M, Lauwigi C, Heinkele G, Mürdter TE, Letzel M (2009) Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment test. Environ Sci Technol 43: 3135-3141.
78. Rieger PG, Meier HM, Gerle M, Vogt U, Groth T, Knackmuss HJ (2002) Xenobiotics in the environment: present and future strategies to obviate the problem of biological persistence. J Biotechnol 94: 101-123.
79. Ruzickova P, Holoubek I, Klanova J (2006) Experimental studies of environmental processes: a practical course in environmental chemistry. Environ Sci Pollut Res 13: 435-440.
80. Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175: 45-95.
81. Schäfer AI, Beder S (2006) Relevance of the precautionary principle in water recycling. Desalination 187: 241-252.
82. Segura PA, Francois M, Gagnon C, Sauve S (2009) Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters. Environ Health Perspect 117: 675-684.
83. Shearouse WC, Waddell DC, Mack J (2009) Alternative solvent-free methodologies in the synthesis of pharmaceutical drugs. Curr Opin Drug Discov Dev 12: 772-783.
84. Singer AC, Nunn MA, Gould EA, Johnson AC (2007) Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 115: 102-106.
85. Singer AC, Howard BM, Johnson AC, Knowles CJ, Jackman S, Accinelli C, Caracciolo AB, Bernard I, Bird S, Boucard T, Boxall A, Brian JV, Cartmell E, Chubb C, Churchley J, Costigan S, Crane M, Dempsey MJ, Dorrington B, Ellor B, Fick J, Holmes J, Hutchinson T, Karcher F, Kelleher SL, Marsden P, Noone G, Nunn MA, Oxford J, Rachwal T, Roberts N, Roberts M, Sacca ML, Sanders M, Straub JO, Terry A, Thomas D, Toovey S, Townsend R, Vouivoulis N, Watts C (2008) Meeting report: risk assessment of tamiflu use under pandemic conditions. Environ Health Perspect 116: 1563-1567.
86. Smith DK (2005) A supramolecular approach to medicinal chemistry: medicine beyond the molecule. J Chem Educ 82: 393-400.
87. Smith SR (2009) Organic contaminants in sewage sludge (biosolids) and their significance for agricultural recycling. Philos Trans R Soc Lond A 367: 4005-4041.
88. Stabile RG, Dicks AP (2003) Microscale synthesis and spectroscopic analysis of flutamide, an antiandrogen prostate cancer drug. J Chem Educ 80: 1439-1443.
89. Stachulski AV, Lennard MS (2000) Drug metabolism: the body's defense against chemical attack. J Chem Educ 77: 349-353.
90. Stockholm County Council (2011) Environmentally Classified Pharmaceuticals, Stockholm. http://www. janusinfo. se/Global/Miljo_och_lakemedel/miljobroschyr_2011_uppslag_eng. pdf. Accessed 2 May 2011.
91. Straub JO (2009) An environmental risk assessment for oseltamivir (Tamiflu (R)) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions. Ecotoxicol Environ Saf 72: 1625-1634.
92. Stumpe B, Marschner B (2009) Factors controlling the biodegradation of 17[beta]-estradiol, estrone and 17[alpha]-ethinylestradiol in different natural soils. Chemosphere 74: 556-562.
93. Sumpter JP (2009) Protecting aquatic organisms from chemicals: the harsh realities. Philos Trans R Soc Lond A 367: 3877-3894.
94. Taggart MA, Senacha KR, Green RE, Jhala YV, Raghavan B, Rahmani AR, Cuthbert R, Pain DJ, Meharg AA (2007) Diclofenac residues in carcasses of domestic ungulates available to vultures in India. Environ Int 33: 759-765.
95. Tatarko M, Tricker J, Andrzejewski K, Bumpus JA, Rhoads H (1999) Remediation of water contaminated with an azo dye: an undergraduate laboratory experiment utilizing an inexpensive photocatalytic reactor. J Chem Educ 76: 1680.
96. Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch H-J, Haist-Gulde B, Preuss G, Wilme U, Zulei-Seibert N (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36: 3855-3863.
97. Tsai CS (2007) Using computer applications and online resources to teach and learn pharmaceutical chemistry. J Chem Educ 84: 2019-2023.
98. United Nations (1992) a) Rio Declaration on Environment and Development; b) Agenda 21, United Nations Conference on Environment and Development, Rio de Janeiro. http://www. un. org/esa/sustdev. Accessed 10 Jul 2008.
99. Vedani A, Schwardt O, Rabbani S, Ernst B (2006) A thorough training in Modem Drug Design. Chimia 60: 70-75.
100. Velagaleti R, Burns PK, Gill M, Prothro J (2002) Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal. Environ Health Perspect 110: 213-220.
101. Voutchkova AM, Osimitz TG, Anastas PT (2010) Toward a comprehensive molecular design framework for reduced hazard. Chem Rev 110: 5845-5882.
102. Wennmalm A, Gunnarsson B (2009) Pharmaceutical management through environmental product labeling in Sweden. Environ Int 35: 775-777.
103. Yu JC, Chan LYL (1998) Photocatalytic degradation of a gaseous organic pollutant. J Chem Educ 75: 750-751.
104. Yuriev E, Chalmers D, Capuano B (2009) Conformational analysis of drug molecules: a practical exercise in the medicinal chemistry course. J Chem Educ 86: 477-478.
105. Zwiener C (2007) Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Anal Bioanal Chem 387: 1159-1162.